Liaoning Boao Bio-pharmaceutical Co., Ltd. jẹ ile-iṣẹ biopharmaceutical igbalode ti o ṣepọ R&D ati iṣelọpọ awọn ọja jara insulin.O bo agbegbe ti awọn mita mita 35,000 ati agbegbe ile ti awọn mita mita 20,000.Awọn ohun-ini ti o wa titi ti o wa tẹlẹ fẹrẹ to 200 milionu RMB.Awọn ọja ile-iṣẹ jẹ pataki ni agbaye asiwaju jiini recombinant amuaradagba oogun recombinant hisulini eniyan, ati awọn oniwe-afọwọṣe gigun-gigun hisulini glargine, ati awọn afọwọṣe iyara-iyara insulin aspart.A ṣe iṣẹ akanṣe yii ni ọdun 2020, ipele isọdi ti a ṣe apẹrẹ jẹ ABC, ati awọn ohun elo iṣelọpọ akọkọ gbogbo ti a gbe wọle lati Jamani.Agbegbe ìwẹnumọ jẹ 6,300 square mita.Ise agbese na nlo awọn ohun elo ile akọkọ-kilasi ile ati imọ-ẹrọ imọ-ẹrọ, gbogbo idanileko naa nlo BIM igbalode lati ṣe apẹẹrẹ ati ṣe itọsọna ikole, iwọn giga ti iṣakoso laifọwọyi ati apẹrẹ oye ti gbogbo idanileko.